howdy Launic, how are you mate?, yes off coarse I'm not suggesting there is need for Merck to jump the gun and make "deals"
at this point in time in regard to keytruda patent expiry in 4 years time.....However the point I was trying to make was they wont wait
until 2028 to address the issue of their prime earner losing it's value to copycats.....Good to see 761 finally get a guernsey and it will be
interesting to see how this progresses because we will enter a different research area, we are sort of drifting away from the survival area
into the comfort precinct....
Media, page-85
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.015(4.41%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $1.270M | 3.611M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 286261 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 253490 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |